Reasons for non-treatment of hepatitis C in veterans in care

Journal of Viral Hepatitis

Volumn 12, Issue 1, 2005, Pages 81-85

  Butt, Adeel A ^a,b,c,e   Wagener, M ^b   Shakil, A O ^d   Ahmad, J ^b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Ctr for Hlth Equity Res and Prom   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e NONE   (United States)

Author keywords

Adherence; Hepatitis C; Treatment; Veterans; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; PEGINTERFERON; VIRUS RNA;

ADULT; AGE; AGED; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; EDUCATION; FEMALE; FOLLOW UP; GENDER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRISONER; PROSPECTIVE STUDY; RACE; SOLDIER; TREATMENT REFUSAL; UNITED STATES;

ADULT; AGED; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 13244284856     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00547.x     Document Type: Article

References (16)

1. Thomas DL, Astemborski J, Rai RM et al. The natural history of hepatitis C infection. Host, viral and environmental factors. J Am Med Assoc 2000; 284: 450-456.
2. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341(8): 556-562.
3. Austin GE, Jensen B, Leete J et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans. Am J Med Sci 2000; 319(6): 353-359.
4. Briggs ME, Baker C, Hall R et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center. Hepatology 2001; 34(6): 1200-1205.
5. Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol 2002; 34(4): 476-480.
6. Roselle GA. National Hepatitis C Surveillance Day in The Department of Veterans Affairs (DVA). Presented at the 37th Annual Meeting of the Infectious Diseases Society of America (IDSA). 18-21 November, 1999; Philadelphia, PA, 2002.
7. Manns MP, McHutchinson JG, Gordon SC et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-965.
8. Fried MW, Shiffman ML, Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347(13): 975-982.
9. McHutchinson JR, Gordon SC, Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 359: 1485-1492.
10. Zeuzem S, Feinman SV, Rasenack J et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 2000; 343: 1666-1672.
11. Bruno S, Battezzatti PM, Bellati G et al. Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol 2001; 34: 748-755.
12. Baffis V, Shrier I, Sherker AH, Szilagyi A. Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients with hepatitis B and hepatitis C virus infection. Ann Intern Med 1999; 131: 696-701.
13. Yoshida H, Shiratori Y, Moriyama M et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999; 131: 174-181.
14. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(Suppl. 1): S11-S19.
15. Thomas DL, Vlahov D, Solomon L et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore) 1995; 74(4): 212-220.
16. Fultz S, Justice AC, Butt AA, Rabeneck L, Rodriguez-Barradas M, Weissman S. Testing, referral, and treatment patterns for hepatitis C coinfection in a cohort of veterans with HIV infection. Clin Infect Dis 2003; 36: 1039-1046.